Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bioverge Ventures is a healthcare venture capital platform based in the United States, founded to democratize access to healthcare innovation. The firm manages a portfolio of 10 companies and invests across various stages, including seed, Series A, Series B, and growth equity.
Bioverge Ventures invests in diversified portfolios of healthcare startups, targeting sectors such as biotechnology, digital health, life sciences, and medical technology. Their investment vehicles include Access Funds, deal-by-deal opportunities, and thematic funds focused on specific technology or disease areas like longevity and cancer.
Notable portfolio companies include: Ancilia Biosciences, a CRISPR-based therapeutic company; Alto Neuroscience, which develops AI-driven precision medicine for psychiatric conditions; Aspen Neuroscience, focused on neuron replacement therapies for Parkinson's disease; Blue Mesa Health, a digital platform for diabetes prevention; and Bionaut Labs, which creates microscale robots for targeted therapy delivery.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.